Literature DB >> 17118184

Malignancy in the blind painful eye--report of two cases and literature review.

Patrícia Rusa Pereira1, Alexandre Nakao Odashiro, João Pessoa Souza Filho, Vinicius S Saraiva, David Gerardo Camoriano, Miguel N Burnier.   

Abstract

BACKGROUND: Few cases of malignant tumors arising in a blind painful eye have previously been described. We described two cases of a blind painful eye containing an unsuspected tumor, which were enucleated to relieve the pain. CASE PRESENTATIONS: Case 1: A 57 year-old Caucasian man presented with recurrent orbital cellulitis and endophthalmitis in the left eye (OS). The OS was blind and painful and an enucleation was performed showing a uveal melanoma by histopathological exam. Case 2: A 54 year-old Caucasian man with previous history of a rhegmatogenous retinal detachment in his left eye presented a blind painful eye. Enucleation was performed revealing a well-differentiated B-cell lymphoma of uveal tract with extra ocular extension.
CONCLUSION: In the management of a blind painful eye, it is extremely important to rule out an intraocular malignancy particularly in those patients who have not been followed by an ophthalmologist.

Entities:  

Year:  2006        PMID: 17118184      PMCID: PMC1679807          DOI: 10.1186/1746-1596-1-45

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


Background

A blind eye may be associated with pain, which is a challenge for the ophthalmologist. The most common conditions leading to the development of a blind painful eye (BPE) are trauma, miscellaneous retinal disorders and retinal detachment, and the majority of these eyes are enucleated to relieve the pain.[1] Few cases of malignant tumors arising from BPE have previously been described. [2-7] From literature review, the frequency of unsuspected intraocular tumors in blind painful eyes has declined over the past twenty years mainly due to ocular ultrasound (US) examination. We described two cases of BPE containing unsuspected tumor, which were enucleated to relieve the pain.

Case presentation

Case 1: A 57 year-old Caucasian man had a previous history of cataract surgery, left eye (OS), in 1984. In 2000, the patient presented with recurrent orbital cellulitis and endophthalmitis OS. The OS was blind and painful and an enucleation was performed (Figure 1A). Histopathology revealed a malignant uveal melanoma, epithelioid cell type (Figure 1B), invading the sclera and orbital tissues. No signs of metastatic disease were detected after four years of follow-up.
Figure 1

A: Gross examination discloses a pupil-optic nerve section presenting a pigmented mass on the choroid with extra-ocular extension. B: Photomicrograph of immunohistochemistry stained with HMB-45 showing strong reaction in almost all cells. The tumor is composed by epithelioid cells with large nuclei and conspicuous nucleoli. (Original magnification 200×). C: Gross examination of pupil-optic nerve section showing a whitish mass committing all uveal tract with extra-ocular extension. D: Haematoxylin and Eosin (H&E) preparation showing tumor in the uveal tract with extra-ocular extension.

A: Gross examination discloses a pupil-optic nerve section presenting a pigmented mass on the choroid with extra-ocular extension. B: Photomicrograph of immunohistochemistry stained with HMB-45 showing strong reaction in almost all cells. The tumor is composed by epithelioid cells with large nuclei and conspicuous nucleoli. (Original magnification 200×). C: Gross examination of pupil-optic nerve section showing a whitish mass committing all uveal tract with extra-ocular extension. D: Haematoxylin and Eosin (H&E) preparation showing tumor in the uveal tract with extra-ocular extension. Case 2: A 54 year-old Caucasian man suffering from Steinert's syndrome had a blind, atrophic OS since 1980. Past medical history includes systemic hypertension and several ophthalmic procedures OS, including a cataract surgery (1971) and a rhegmatogenous retinal detachment (1978). In 1992, the patient presented with pain in the OS and an uneventful enucleation was performed (Figure 1C). Histopathologic examination disclosed a monotonous and diffuse proliferation of small lymphocytes in the uveal tract with extra ocular extension. Immunohistochemical study was strongly positive for CD20 (B lymphocytes) and negative for CD45RO (T lymphocytes), consistent with a well-differentiated B-cell lymphoma (Figure 1D). No signs of systemic involvement were detected. The patient was lost to follow-up six years after surgery. Severe pain may develop in blind eyes for various reasons including surgical and non-surgical trauma, and retinal detachment. Management of a blind painful eye represents a challenge for the ophthalmologist and is limited to topical medications, retrobulbar alcohol injection, evisceration or enucleation.[1] Relief of ocular pain is the most common reason that enucleation is performed in BPE.[1] In the past, ocular melanomas arising in a BPE could account for more than 10% of all diagnosed uveal melanomas.[8] Volcker and Naumann[9] in 1976 described 36 cases of unsuspected ocular melanoma that were diagnosed after enucleation. The clinical diagnoses in those cases were secondary glaucoma (30), retinal detachment (2), iritis (2), and end/panophthalmitis (2). Review of the literature today shows that the clinical suspicion rate of an intraocular malignancy in BPE is not well established. Previous studies of enucleated globes do not correlate blindness with unsuspected intraocular tumors.[10] In this particular report, the unsuspected melanoma was present in a blind painful eye of a mentally handicapped patient. Intraocular lymphomas of the uveal tract have been discovered in functional eyes with symptoms of retinal detachment and increased intraocular pressure. Intraocular tumors arising in blind painful eyes are probably under diagnosed and underreported. Several uveal melanomas, [4,5,7] two adenocarcinomas of the retinal pigment epithelium [2,3] and an unspecified sarcoma [6] have been described (Table 1). In two of those cases, enucleation was performed to relieve the pain and an early stage malignant tumor was found,[2,7] leading to a good prognosis. However, in cases with advanced disease and extra-ocular involvement, an enucleation was performed due to a high index of suspicion of an intraocular malignancy.[4-6] In those cases the prognosis was poor.
Table 1

Malignant tumor in previous blind eyes

AuthorsPatientEyeSigns/SymptomsSuspicious malignancyTreatmentPathologic diagnosisFollow-up
Ten Thije666-year-old, manREExophthalmosYesExenterationLarge-cell sarcomaDeath few months after diagnostic
Sarma et al562-year-old, manLEProgressive proptosis, eye pain, left orbit massYesExenterationExtrascleral Uveal melanomaNo follow-up reported
Nelson & Kincaid470-year-old, manLEdark inferonasal and superiorly conjunctival mass, mass in the anterior chamberYesExenterationExtrascleral Uveal melanoma (ciliary body)Pulmonary and bone metastasis, death 1 year after diagnostic
Nelson & Kincaid479-year-old, manREeye pain, black exophytic subconjunctival massYesExenterationExtrascleral Uveal melanomaLiver metastasis 8 months later, death 14 months after diagnostic
Loeffler et al366-year-old, manREeye painNoEnucleationMalignant tumor of the retinal pigment epitheliumNo death or metastasis 1 year after enucleation
Edelstein et al279-year-old, womanREeye pain, exophthalmosNoEnucleationPresumed Adenocarcinoma of the retinal pigment epithelium with staphylomaNo follow-up reported
Tripathi et al745-year-oldREEye painNoEnucleationUveal melanomaNo follow-up reported
Pereira et al57-year-old, manLEeye pain, endophthalmitis, orbital cellulitesNoEnucleationExtrascleral Uveal melanomaNo signs of metastatic disease after four years of follow-up
Pereira et al54-year-old, manLEeye painNoEnucleationExtranodal lymphoma of uveal tract with extra ocular extensionLost to follow-up after six years
Malignant tumor in previous blind eyes Several authors emphasized the importance of ultrasonographic studies to diagnose intraocular tumors in blind painful eyes.[5,11]

Conclusion

In the management of a blind painful eye, it is extremely important to rule out an intraocular malignancy particularly in those patients who have not been followed by an ophthalmologist. In these cases, it is the duty of the attending physician to emphasize to the patient the importance of regular examination of the blind eye because, like in all malignancies, advanced disease leads to a worse prognosis.[4] The present report also emphasizes the importance of subjecting enucleated globes to a histopathological examination, since an unsuspected intraocular malignancy may be hidden in a blind painful eye.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

PRP wrote the manuscript ANO, JPSP and VS revised the histopathology of the cases and the manuscript DGC prepared the pictures and revised the manuscript MNB revised the entire manuscript
  11 in total

1.  Malignant melanoma and massive retinal gliosis in phthisis bulbi.

Authors:  A Tripathi; P Hiscott; B E Damato
Journal:  Eye (Lond)       Date:  2002-11       Impact factor: 3.775

2.  Enucleation of blind, painful eyes.

Authors:  P L Custer; C E Reistad
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-09       Impact factor: 1.746

3.  Presumed adenocarcinoma of the retinal pigment epithelium in a blind eye with a staphyloma.

Authors:  C Edelstein; C L Shields; J A Shields; R C Eagle
Journal:  Arch Ophthalmol       Date:  1998-04

4.  Malignant tumor of the retinal pigment epithelium with extraocular extension in a phthisical eye.

Authors:  K U Loeffler; T Kivelä; H Borgmann; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Sarcoma in an atrophic eye.

Authors:  P A ten Thije
Journal:  Ophthalmologica       Date:  1968       Impact factor: 3.250

6.  Extrascleral malignant melanoma.

Authors:  C C Nelson; M C Kincaid
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1992       Impact factor: 1.746

7.  Clinicopathologic correlations in 646 consecutive surgical eye specimens, 1990-2000.

Authors:  Anna S Kitzmann; Amy L Weaver; Christine M Lohse; Helmut Buettner; Diva R Salomão
Journal:  Am J Clin Pathol       Date:  2003-04       Impact factor: 2.493

8.  [Clinically unsuspected malignant melanomas of the posterior uvea (author's transl)].

Authors:  H E Völcker; G O Naumann
Journal:  Klin Monbl Augenheilkd       Date:  1976-03       Impact factor: 0.700

9.  The diagnosis of uveal malignant melanomas in eyes with opaque media.

Authors:  J A Shields; P R McDonald; B C Leonard; C L Canny
Journal:  Am J Ophthalmol       Date:  1977-01       Impact factor: 5.258

Review 10.  Malignant melanoma in a blind eye.

Authors:  D P Sarma; S J Deshotels; J H Lunseth
Journal:  J Surg Oncol       Date:  1983-07       Impact factor: 3.454

View more
  5 in total

Review 1.  Ciliochoroidal melanoma presenting as bleeding anterior staphyloma: Report of a case and review of literature.

Authors:  Md Shahid Alam; Andrea Tongbram; Subramanian Krishnakumar; Bipasha Mukherjee
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

Review 2.  [Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-26       Impact factor: 1.059

3.  Malignant melanoma of conjunctiva: Diagnosis on fine-needle aspiration cytology.

Authors:  Manjari Kishore; Vijay Kumar; Manju Kaushal
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

4.  Uveal melanoma presenting as cataract and staphyloma.

Authors:  Vikas Khetan; Kshanada Gupta; E Ravindra Mohan; Lingam Gopal
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

5.  Necrotic uveal melanoma presenting as orbital cellulitis with intraocular hemorrhage: A case report.

Authors:  Alexa L Li; Julia Y Kang; Duncan E Berry; Krishna B Patel; Andrew M Hendrick
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.